Protalix BioTherapeutics, Inc. (NYSE:PLX) Q3 2022 Results Conference Call November 14, 2022 8:30 AM ET Company Participants Chuck Padala - LifeSci Advisors Dror Bashan - President, CEO Eyal Rubin - SVP, CFO Conference Call Participants Boobalan Pachaiyappan - H.C. Wainwright John Vandermosten - Zacks Operator Greetings, and welcome to the Protalix BioTherapeutics Third Quarter 2022 Financial and Business Results Conference Call. [Operator Instructions] As a reminder, this conference is being recorded. It ...